Wang 2006.
Methods | Eight‐week, (likely) randomised study. |
Participants | In‐ and out‐patients with depression according to CCMD‐III criteria. |
Interventions | Citalopram: 25 participants. Mirtazapine: 25 participants. Citalopram dose range: 20‐40 mg/day. mirtazapine dose range: 15‐30 mg/day. |
Outcomes | Change in Hamilton Depression Rating Scale 17 Item (HDRS‐17) score from baseline to endpoint, number of patients who responded to treatment. |
Notes | Waiting for translation from Chinese to English (only abstract available in English). |